Effect of saccharin on inflammation in 3T3-L1 adipocytes and the related mechanism
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Excessive intake of simple sugars induces obesity and increases the risk of inflammation. Thus, interest in alternative sweeteners as a sugar substitute is increasing. The purpose of this study was to determine the effect of saccharin on inflammation in 3T3-L1 adipocytes. MATERIALS/METHODS: 3T3-L1 preadipocytes were differentiated into adipocytes. The adipocytes were treated with saccharin (0, 50, 100, and 200 μg/mL) for 24 h. Inflammation was induced by exposure of treated adipocytes to lipopolysaccharide (LPS) for 18 h and cell proliferation was measured. The concentration of nitric oxide (NO) was measured by using Griess reagent. Protein expressions of nuclear factor kappa B (NF-κB) and inhibitor κB (IκB) were determined by western blot analysis. The mRNA expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin 1β (IL-1β), interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α) were determined by real-time PCR. RESULTS: Compared with the control group, the amount of NO and the mRNA expression of iNOS in the LPS-treated group were increased by about 17.6% and 46.9%, respectively, (P < 0.05), and those parameter levels were significantly decreased by saccharin treatment (P < 0.05). Protein expression of NF-κB was decreased and that of IκB was increased by saccharin treatment (P < 0.05). Saccharin decreased the mRNA expression of COX-2 and the inflammation cytokines (IL-1β, IL-6, MCP-1, and TNF-α) (P < 0.05). CONCLUSIONS: The results of this study suggest that saccharin can inhibit LPS-induced inflammatory responses in 3T3-L1 adipocytes via the NF-κB pathway.
Abstract
BACKGROUND/OBJECTIVES: Excessive intake of simple sugars induces obesity and increases the risk of inflammation. Thus, interest in alternative sweeteners as a sugar substitute is increasing. The purpose of this study was to determine the effect of saccharin on inflammation in 3T3-L1 adipocytes. MATERIALS/METHODS: 3T3-L1 preadipocytes were differentiated into adipocytes. The adipocytes were treated with saccharin (0, 50, 100, and 200 μg/mL) for 24 h. Inflammation was induced by exposure of treated adipocytes to lipopolysaccharide (LPS) for 18 h and cell proliferation was measured. The concentration of nitric oxide (NO) was measured by using Griess reagent. Protein expressions of nuclear factor kappa B (NF-κB) and inhibitor κB (IκB) were determined by western blot analysis. The mRNA expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin 1β (IL-1β), interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α) were determined by real-time PCR. RESULTS: Compared with the control group, the amount of NO and the mRNA expression of iNOS in the LPS-treated group were increased by about 17.6% and 46.9%, respectively, (P < 0.05), and those parameter levels were significantly decreased by saccharin treatment (P < 0.05). Protein expression of NF-κB was decreased and that of IκB was increased by saccharin treatment (P < 0.05). Saccharin decreased the mRNA expression of COX-2 and the inflammation cytokines (IL-1β, IL-6, MCP-1, and TNF-α) (P < 0.05). CONCLUSIONS: The results of this study suggest that saccharin can inhibit LPS-induced inflammatory responses in 3T3-L1 adipocytes via the NF-κB pathway.
참고문헌 (34)
- Aller EE, "Starches, sugars and obesity", Nutrients, 3, pp.341~369 (2011)
- Ludwig DS, "Relation between consumption of sugar-sweetened drinks and childhood obesity : a prospective, observational analysis", Lancet, 357, pp.505~508 (2001)
- Hu FB, "Sugar-sweetened beverages and risk of obesity and type 2 diabetes : epidemiologic evidence", Physiol Behav, 100, pp.47~54 (2010)
- Beilharz JE, "Short-term exposure to a diet high in fat and sugar, or liquid sugar, selectively impairs hippocampaldependent memory, with differential impacts on inflammation", Behav Brain Res, 306, pp.1~7 (2016)
- Schäffler A, "Role of adipose tissue as an inflammatory organ in human diseases", Endocr Rev, 27, pp.449~467 (2006)
- Fantuzzi G, "Adipose tissue, adipokines, and inflammation", J Allergy Clin Immunol, 115, pp.911~919 (2005)
- Oeckinghaus A, "The NF-kappaB family of transcription factors and its regulation", Cold Spring Harb Perspect Biol, 1, pp.a000034~ (2009)
- Chattopadhyay S, "Artificial sweeteners-a review", J Food Sci Technol, 51, pp.611~621 (2014)
- Ju DL, "The efficacy and safety of non-nutritive sweeteners", J Korean Diabetes, 16, pp.281~286 (2015)
- Mondal S, "Enhancement of oncogenesis in C3H", 10T1, Science, pp.1978, 201[DOI]
- Chowaniec J, "Response of the rat to saccharin with particular reference to the urinary bladder", Br J Cancer, 39, pp.355~375 (1979)
- Mortensen A, "Sweeteners permitted in the European Union : safety aspects", Scand J Food Nutr, 50, pp.104~116 (2006)
- 김정원, "삭카린의 안전성과 각국의 관리 현황", 한국식품과학회지, 43(6), pp.659~674 (2011), 한국식품과학회
- Cohen SM, "Safety of saccharin", Agro Food Ind Hi Tech, 19, pp.24~28 (2008)
- 최정수, "다양한 암세포 주와 MSCs에 대한 Saccharin의 항증식성 평가", 대한임상검사과학회지, 48(3), pp.169~175 (2016), 대한임상검사과학회
- 박종민, "구속 스트레스 쥐 모델에서 스트레스 반응 감소에 대한 사카린 섭취의 효과", Journal of Korean Biological Nursing Science, 18(1), pp.36~42 (2016), 한국기초간호학회
- Lee LS, "Saccharin and cyclamate inhibit binding of epidermal growth factor", Proc Natl Acad Sci U S A, 78, pp.1042~1046 (1981)
- Thompson MM, "Hypoglycemic effects of saccharin in experimental animals", Am J Clin Nutr, 7, pp.80~85 (1959)
- Bailey CJ, "Antihyperglycaemic effect of saccharin in diabetic ob", ob mice, 1997, pp.120, 74~78
- Csakai A, "Saccharin derivatives as inhibitors of interferon-mediated inflammation", J Med Chem, 57, pp.5348~5355 (2014)
- Glushakova O, "Fructose induces the inflammatory molecule ICAM-1 in endothelial cells", J Am Soc Nephrol, 19, pp.1712~1720 (2008)
- DiNicolantonio JJ, "Fructoseinduced inflammation and increased cortisol : a new mechanism for how sugar induces visceral adiposity", Prog Cardiovasc Dis, 61, pp.3~9 (2018)
- Cullberg KB, "Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro", Nutr Diabetes, 4, pp.e113~ (2014)
- Dobashi K, "Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats", Life Sci, 67, pp.2093~2101 (2000)
- Brasier AR, "The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation", Cardiovasc Res, 86, pp.211~218 (2010)
- Nakajima S, "Bidirectional regulation of NF-κB by reactive oxygen species : a role of unfolded protein response", Free Radic Biol Med, 65, pp.162~174 (2013)
- Boonkaewwan C, "Anti-inflammatory and immunomodulatory activities of stevioside and steviol on colonic epithelial cells", J Sci Food Agric, 93, pp.3820~3825 (2013)
- Legler DF, "Prostaglandin E2 at new glance : novel insights in functional diversity offer therapeutic chances", Int J Biochem Cell Biol, 42, pp.198~201 (2010)
- Lee W, "Xylose-taurine reduced suppresses the inflammatory responses in lipopolysaccharide-stimulated Raw264. 7 macrophages", Adv Exp Med Biol, 975, pp.633~642 (2017)
- Ballak DB, "IL-1 family members in the pathogenesis and treatment of metabolic disease : Focus on adipose tissue inflammation and insulin resistance", Cytokine, 75, pp.280~290 (2015)
- Su C, "Testosterone enhances lipopolysaccharide-induced interleukin-6 and macrophage chemotactic protein-1expression by activating the extracellular signal-regulated kinase 1", 2, Mol Med Rep, pp.2015, 12[DOI]
- Blancas-Flores G, "Glycine suppresses TNF-α-induced activation of NF-κB in differentiated 3T3-L1 adipocytes", Eur J Pharmacol, 689, pp.270~277 (2012)
- 김선영, "NF-κB와 MAPK 억제를 통한 스테비아 잎의 항염증효과", 한방안이비인후피부과학회지, 26(3), pp.54~64 (2013), 대한한방안이비인후피부과학회
- Wang Z, "Stevioside ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by downregulating the NF-κB pathway", Biochem Biophys Res Commun, 417, pp.1280~1285 (2012)